{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Respiratory+Therapy&page=22", "query": { "condition": "Respiratory Therapy", "page": 22 }, "page_size": 10 }, "pagination": { "page": 22, "page_size": 10, "total_count": 4663, "total_pages": 467, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Respiratory+Therapy&page=23&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Respiratory+Therapy&page=21&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-23T02:11:39.103Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04605588", "title": "A Triple Combination Antiviral Coronavirus Therapy (TriACT) for COVID-19", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "SARS-CoV Infection", "Covid19" ], "interventions": [ { "name": "Nitazoxanide", "type": "DRUG" }, { "name": "Placebo Nitazoxanide", "type": "DRUG" }, { "name": "Ribavirin", "type": "DRUG" }, { "name": "Placebo Ribavirin", "type": "DRUG" }, { "name": "Hydroxychloroquine", "type": "DRUG" }, { "name": "Placebo Hydroxychloroquine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Rutgers, The State University of New Jersey", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 7, "start_date": "2020-12-02", "completion_date": "2021-02-04", "has_results": true, "last_update_posted_date": "2022-05-05", "last_synced_at": "2026-10-23T02:11:39.103Z", "location_count": 1, "location_summary": "New Brunswick, New Jersey", "locations": [ { "city": "New Brunswick", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT04605588" }, { "nct_id": "NCT07123961", "title": "Pediatric Acute Respiratory Distress Syndrome (ARDS) Management Trial", "overall_status": "SUSPENDED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Respiratory Distress Syndrome (ARDS)", "Ventilator Management", "Lung-protective Ventilation", "Pediatric Acute Respiratory Distress Syndrome (PARDS)" ], "interventions": [ { "name": "High Driving Pressure Mechanical Ventilation", "type": "OTHER" }, { "name": "Low Driving Pressure Mechanical Ventilation", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Children's Hospital of Philadelphia", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Weeks", "maximum_age": "17 Years", "sex": "ALL", "summary": "2 Weeks to 17 Years" }, "enrollment_count": 160, "start_date": "2025-11-07", "completion_date": "2030-06-30", "has_results": false, "last_update_posted_date": "2026-08-14", "last_synced_at": "2026-10-23T02:11:39.103Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT07123961" }, { "nct_id": "NCT04294641", "title": "Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic GVHD" ], "interventions": [ { "name": "Ibrutinib", "type": "DRUG" }, { "name": "ECG", "type": "DIAGNOSTIC_TEST" }, { "name": "PFT's", "type": "DIAGNOSTIC_TEST" }, { "name": "CT", "type": "DIAGNOSTIC_TEST" }, { "name": "Steroid pulse (prednisone)", "type": "DRUG" }, { "name": "Voriconazole", "type": "DRUG" }, { "name": "Posaconazole", "type": "DRUG" }, { "name": "Azithromycin", "type": "DRUG" }, { "name": "Montelukast", "type": "DRUG" }, { "name": "Budesonide", "type": "DRUG" }, { "name": "Beclomethasone", "type": "DRUG" }, { "name": "Filgrastim", "type": "OTHER" }, { "name": "Pegfilgrastim", "type": "OTHER" }, { "name": "Erythropoietin", "type": "OTHER" }, { "name": "Transfusions", "type": "OTHER" }, { "name": "Oral/Skin biopsy", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "DIAGNOSTIC_TEST", "OTHER", "PROCEDURE" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 10, "start_date": "2021-05-10", "completion_date": "2024-10-01", "has_results": true, "last_update_posted_date": "2026-01-23", "last_synced_at": "2026-10-23T02:11:39.103Z", "location_count": 2, "location_summary": "Bethesda, Maryland • St Louis, Missouri", "locations": [ { "city": "Bethesda", "state": "Maryland" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT04294641" }, { "nct_id": "NCT04946318", "title": "Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "CSJ117", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 136, "start_date": "2021-09-08", "completion_date": "2022-09-08", "has_results": false, "last_update_posted_date": "2022-10-10", "last_synced_at": "2026-10-23T02:11:39.103Z", "location_count": 10, "location_summary": "Bakersfield, California • Huntington Beach, California • Los Angeles, California + 6 more", "locations": [ { "city": "Bakersfield", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Marietta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04946318" }, { "nct_id": "NCT01757288", "title": "Phase I/II NabPaclitaxel, Paclitaxel&Carboplatin w RTX Followed by Consolidation in Patients w Favorable Prognosis Inoperable Stage IIIA/B NSCLC", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER" ], "interventions": [ { "name": "NAB-PACLITAXEL", "type": "DRUG" }, { "name": "PACLITAXEL", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Texas Southwestern Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 98, "start_date": "2013-03-25", "completion_date": "2019-06-03", "has_results": true, "last_update_posted_date": "2021-10-28", "last_synced_at": "2026-10-23T02:11:39.103Z", "location_count": 5, "location_summary": "Rochester, New York • Pittsburgh, Pennsylvania • Nashville, Tennessee + 1 more", "locations": [ { "city": "Rochester", "state": "New York" }, { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Nashville", "state": "Tennessee" }, { "city": "Nashville", "state": "Tennessee" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01757288" }, { "nct_id": "NCT07361497", "title": "A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Non-small Cell Lung Cancer (NSCLC)" ], "interventions": [ { "name": "Pumitamig", "type": "DRUG" }, { "name": "Durvalumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 850, "start_date": "2026-03-16", "completion_date": "2034-01-13", "has_results": false, "last_update_posted_date": "2026-09-30", "last_synced_at": "2026-10-23T02:11:39.103Z", "location_count": 38, "location_summary": "Daphne, Alabama • Golden, Colorado • Newark, Delaware + 32 more", "locations": [ { "city": "Daphne", "state": "Alabama" }, { "city": "Golden", "state": "Colorado" }, { "city": "Newark", "state": "Delaware" }, { "city": "Ocala", "state": "Florida" }, { "city": "Plantation", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07361497" }, { "nct_id": "NCT01014988", "title": "Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Influenza, Human" ], "interventions": [ { "name": "zanamivir aqueous solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": null, "sex": "ALL", "summary": "6 Months and older" }, "enrollment_count": 202, "start_date": "2009-11", "completion_date": "2015-02", "has_results": true, "last_update_posted_date": "2017-03-28", "last_synced_at": "2026-10-23T02:11:39.103Z", "location_count": 40, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 33 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "San Diego", "state": "California" }, { "city": "Stamford", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT01014988" }, { "nct_id": "NCT00391768", "title": "Oseltamivir Treatment for Children Less Than 24 Months of Age With Influenza", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "oseltamivir (Tamiflu®)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "23 Months", "sex": "ALL", "summary": "Up to 23 Months" }, "enrollment_count": 87, "start_date": "2007-01", "completion_date": "2010-04", "has_results": true, "last_update_posted_date": "2013-05-01", "last_synced_at": "2026-10-23T02:11:39.103Z", "location_count": 29, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • Long Beach, California + 24 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Long Beach", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00391768" }, { "nct_id": "NCT04843761", "title": "ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Covid19" ], "interventions": [ { "name": "Remdesivir", "type": "BIOLOGICAL" }, { "name": "Remdesivir Placebo", "type": "DRUG" }, { "name": "Aviptadil", "type": "BIOLOGICAL" }, { "name": "Aviptadil Placebo", "type": "DRUG" }, { "name": "Corticosteroid", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 473, "start_date": "2021-04-20", "completion_date": "2022-11-20", "has_results": true, "last_update_posted_date": "2025-10-24", "last_synced_at": "2026-10-23T02:11:39.103Z", "location_count": 40, "location_summary": "Tucson, Arizona • Fresno, California • Loma Linda, California + 28 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Fresno", "state": "California" }, { "city": "Loma Linda", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04843761" }, { "nct_id": "NCT02573870", "title": "Batefenterol/Fluticasone Furoate in Treatment of Chronic Obstructive Pulmonary Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Batefenterol + Fluticasone Furoate", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Albuterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 63, "start_date": "2015-12-01", "completion_date": "2016-07-05", "has_results": true, "last_update_posted_date": "2020-07-21", "last_synced_at": "2026-10-23T02:11:39.103Z", "location_count": 10, "location_summary": "Phoenix, Arizona • Hollywood, Florida • Baltimore, Maryland + 7 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Hollywood", "state": "Florida" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Charlotte", "state": "North Carolina" }, { "city": "Gastonia", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02573870" } ] }